Abstract
To report three patients who developed unilateral choroidal neovascularization (CNV) following laser in situ keratomileusis (LASIK) for high myopia. Retrospective chart reviews of three highly myopic patients who developed CNV following LASIK and who attended a tertiary care private practice were conducted. The clinical presentation of the patients was analyzed. All patients were treated with a combination of intravitreal ranibizumab and photodynamic therapy with verteporfin. Main outcome measures were clinical fundus appearance and best-corrected visual acuity (BCVA) after treatment. Two females and one male with a mean age of 34 ± 2.8 years underwent LASIK for high myopia in both eyes. The mean spherical equivalent was −11.42 diopters (D) (range −6.75 to −20.00). The mean time interval between LASIK and the appearance of symptoms was 9.3 ± 8.5 weeks. One patient developed an extrafoveal CNV at the edge of a laser photocoagulation scar, one developed a subfoveal CNV and the third patient developed a juxtafoveal CNV. The mean BCVA at the time of CNV presentation was 0.44 logMAR (range 0.10–0.70 logMAR). Following treatment, the mean BCVA improved to 0.17 logMAR with complete resolution of CNV in two patients. CNV is a rare but potentially blinding complication following LASIK. Short-term good visual outcome can be achieved with timely intervention with current treatment modalities.
Similar content being viewed by others
References
Ho TK (2007) The development of refractive surgery: a practical perspective. Singapore Med J 48(8):706
Pallikaris IG, Papatzanaki ME, Siganos DS, Tsilimbaris MK (1991) A corneal flap technique for laser in situ keratomileusis. Human studies. Arch Ophthalmol 109:1699–1702
Moretti M (1999) U.S. laser vision correction market explodes. Eye World 12:29–31
Melki SA, Azar DT (2001) LASIK complications: etiology, management and prevention. Surv Ophthalmol 46:95–116
Alireza M, Holger B (2009) Posterior segment complications of laser in situ keratomileusis (LASIK). Surv Ophthalmol 54:433–440
Chen YC, Ma DKH, Yang KJ, Chen TL, Li CY, Lai CC (2001) Bilateral choroidal neovascularization after laser-assisted in situ keratomileusis. Retina 21(2):174–175
Ruiz-Moreno JM, Alió JL (2003) Incidence of retinal disease following refractive surgery in 9,239 eyes. J Refract Surg 9(5):534–547
Maturi RK, Kitchens JW, Spitzberg DH, Yu M (2003) Choroidal neovascularization after LASIK. J Refract Surg 19(4):463–464
Arevalo JF, Ruiz-Moreno JM, Fernandez CF, Medoza AJ, Ramirez E, Montero JA (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis. Ophthalmic Surg Lasers Imaging 35(1):58–62
Saeed M, Poon W, Goyal S, McHugh D, Lee N (2004) Choroidal neovascularization after laser in situ keratomileusis in a patient with low myopia. J Cataract Refract Surg 30(12):2632–2635
Pinto RV, Smiddy WE, Culbertson W (2004) Choroidal neovascularization following laser in situ keratomileusis. Ophthalmic Surg Lasers Imaging 35(1):63–66
Amat-Peral P, Lugo F, Montero JA et al (2008) Photodynamic therapy with verteporfin in choroidal neovascularization after refractive surgery. Arch Soc Esp Oftalmol 83:539–544
Wong TY, Foster PJ, Hee J et al (2000) Prevalence and risk factors for refractive errors in adult Chinese residents in Singapore. Invest Ophthalmol Vis Sci 41:2486–2494
Curtin BJ (1977) The posterior staphyloma of pathologic myopia. Trans Am Ophthalmol Soc 75:67–86
Johnson DA, Yannuzzi LA, Shakin JL, Lightman DA (1998) Lacquer cracks following neovascularization in pathologic myopia. Retina 18:118–124
Curtin BJ, Karlin DB (1971) Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 71:42–53
Ohno-Matsui K, Yoshida T, Futagami S et al (2003) Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 87:570–573
Brancato R, Menchini U, Pece A et al (2011) Dye laser photocoagulation of macular subretinal neovascularization in pathological myopia. A randomized study of three different wavelengths. Int Ophthalmol 11:235–238
Pece A, Brancato R, Avanza P et al (1995) Laser photocoagulation of choroidal neovascularization in pathologic myopia: long-term results. Int Ophthalmol 18:339–344
Secretan M, Kuhn D, Soubrane G et al (1997) Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 7:307–316
Principe AH, Lin DY, Small KW, Aldave AJ (2004) Macular hemorrhage after laser in situ keratomileusis (LASIK) with femtosecond laser flap creation. Am J Ophthalmol 138:657–659
Mian SI, Shtein RM (2007) Femtosecond laser-assisted corneal surgery. Curr Opin Ophthalmol 18:295–299
Hernandez-Verdejo JL, Teus MA, Roman JM et al (2007) Porcine model to compare real-time intraocular pressure during LASIK with a mechanical microkeratome and femtosecond laser. Invest Ophthalmol Vis Sci 48(1):68–72
Dick BH, Willert A, Elling M (2011) Real-time measurement of intraocular pressure during femtosecond laser enabled keratoplasty. J Refract Surg 27(6):399–400
Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin, 1-year results of a randomized clinical trial-VIP Report No 1. Ophthalmology 108:841–852
Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia. 2-year results of a randomized clinical trial—VIP Report No 3. Ophthalmology 110:667–673
Neelam K, Cheung CM, Ohno-Matsui K et al (2012) Choroidal neovascularization in pathological myopia. Prog Retin Eye Res 31:495–525
Baba T, Kubota-Taniai M, Kitahashi M et al (2010) Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularization. Br J Ophthalmol 94:864–870
Ikuno Y, Nagai Y, Matsuda S et al (2010) Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. Am J Ophthalmol 149:140–146
Yoon JU, Byun YJ, Koh HJ (2010) Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina 30:418–424
Grossniklaus HE, Hutchinson AK, Capone A (1992) Pathologic findings in pathologic myopia. Retina 12:127–133
Augustin AJ, Offermann (2007) Combination therapy for choroidal neovascularization. Drugs Aging 24(12):979–990
Desco CM, Mataix J, Garcia-Pous M et al (2011) Photodynamic therapy and bevacizumab to treat myopic neovascular membranes. 1-year follow-up. Retina 31:475–481
Han DP, McAllister JT, Weinberg DV (2010) Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation. Eye 24:713–716
Acknowledgments
The authors would like to thank Mr Albert Sim of Khoo Teck Puat Hospital for putting together images for this article. The authors have not received any grants nor funding for this work.
Conflicts of interest
There are no competing interests and the authors have no proprietary interests in the materials presented herein.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Neo, H.Y., Neelam, K., Yip, C.C. et al. Choroidal neovascularization following laser in situ keratomileusis for high myopia: a case series. Int Ophthalmol 33, 27–34 (2013). https://doi.org/10.1007/s10792-012-9622-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-012-9622-5